NRXP
NRX Pharmaceuticals Inc
3.00$
-4.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | – | – | +232,458.1% | +0.0% | +100.0% | +25.0% | +0.0% | +2,760.0% | |
| – | – | – | +78,066.8% | +966.4% | -53.4% | -89.3% | +25.6% | -53.1% | |
| – | – | – | +3,540.2% | +30.9% | – | – | – | – | |
| – | – | -99.2% | +73,966.9% | -241.8% | – | +638.8% | +2.5% | -73.4% | |
| – | – | – | +199,900.0% | +250.0% | +42.9% | -70.0% | -100.0% | – | |
| – | -99.1% | – | -100.0% | +250.0% | +42.9% | -70.0% | – | – | |
| – | – | – | -35.4% | – | – | – | – | – | |
| – | – | – | +0.0% | -305.9% | – | -132.5% | -51.6% | – | |
| – | -99.0% | -5,882.4% | – | +1,853.1% | -49.2% | -80.8% | +20.7% | +211.0% | |
| – | -197.5% | – | – | +2,521.8% | -129.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.